Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review.
Journal: Translational pediatrics
Published: December 18, 2023
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
Journal: Journal of clinical medicine
Published: February 27, 2021
Advances in the Diagnosis and Management of Neonatal Sarcomas.
Journal: Clinics in perinatology
Published: February 15, 2021
A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling.
Journal: Biology open
Published: December 29, 2020
Advances in the management of pediatric genitourinary rhabdomyosarcoma.
Journal: Translational andrology and urology
Published: November 19, 2020
More Than Meets the Eye? A Cautionary Tale of Malignant Ectomesenchymoma Treated as Low-risk Orbital Rhabdomyosarcoma.
Journal: Journal of pediatric hematology/oncology
Published: April 23, 2020
RASSF4 is required for skeletal muscle differentiation.
Journal: Cell biology international
Published: March 08, 2019
The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.
The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2017
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.
Journal: Frontiers in oncology
Published: May 22, 2015
Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.
Journal: Pediatric blood & cancer
Published: February 26, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026